Onglyza

Active Ingredient(s): Saxagliptin Hydrochloride
FDA Approved: * July 31, 2009
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Diabetes

Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class.[1][2] Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug. In April 2016, the U.S. FDA added a warning about increased risk of heart failure.[3] This was based on data ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Onglyza 2;5;4214
Onglyza 2.5 mg Oral Tablet
NDC: 0003-4214
Labeler:
E.r. Squibb & Sons, L.L.C.
Onglyza 5;4215
Onglyza 5 mg Oral Tablet
NDC: 0003-4215
Labeler:
E.r. Squibb & Sons, L.L.C.
Onglyza 2;5;4214
Onglyza 2.5 mg Oral Tablet, Film Coated
NDC: 0310-6100
Labeler:
Astrazeneca Pharmaceuticals Lp
Onglyza 5;4215
Onglyza 5 mg Oral Tablet, Film Coated
NDC: 0310-6105
Labeler:
Astrazeneca Pharmaceuticals Lp
Onglyza 5;4215
Onglyza 5 mg Oral Tablet
NDC: 54868-6309
Labeler:
Physicians Total Care, Inc.
Onglyza 5;4215
Onglyza 5 mg Oral Tablet, Film Coated
NDC: 55154-0611
Labeler:
Cardinal Health
Onglyza 5;4215
Onglyza 5 mg Oral Tablet, Film Coated
NDC: 55154-6931
Labeler:
Cardinal Health

Popular Topics

Onglyza 5mg cetapin 1000mg

I have been given onglyza 5mg in morning with cetapin500 mg and after dinner cetapin 1000mg Earlier I was taking 1/2 gli...